Retinal Imaging Devices Market Growth and Forecast by 2028

The retinal imaging devices market is projected to reach US$ 3.00 billion by 2028 from US$ 2.06 billion in 2021; it is estimated to grow at a CAGR of 5.6% during 2021–2028.

Retinal imaging is a technique that is used to analyze and diagnose the condition of a patient's retina. Retinal imaging devices (RID) use high-resolution imaging systems to capture inside pictures of an eye. The captured image helps Virtual Private Network (VSP) network doctors assess the health of the retina, which helps in the detection and management of eye and health conditions such as diabetes, glaucoma, and macular degeneration, amongst others.

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Retinal Imaging Devices Market: Strategic Insights

The growth of the retinal imaging devices market is attributed to the improved ophthalmologists’ access to the retina, growing global initiatives for blindness and technological advancements. However, the high cost of OCT devices hampers the market growth. 

Market Insights
Rising prevalence of eye diseases

Retinal imaging devices are widely used to diagnose and treat various eye-related diseases such as diabetic retinopathy, age-related macular degeneration, glaucoma, ocular melanoma, and mild vision problems. In addition, across the world, concern for blindness or vision impairment is growing significantly. According to the data published by the World Health Organization (WHO) in October 2021, nearly 2.2 billion people live with a vision impairment or blindness. Among which approximately one billion vision impairment cases can be prevented by proper diagnosis and treatment. These one billion people have different eye problems related to moderate or severe distance vision impairment or blindness. Image-related diagnostic technologies have begun to offer unprecedented growth into eye diseases based on morphological datasets. Such a factor is expected to aid the retinal imaging devices market over the forecast period.

Device Type-Based Insights

Based on device type, the global retinal imaging devices market has been segmented into fluorescein angiography, fundus camera, and optical coherence tomography. The fundus camera segment held the largest share of the market in 2021. Fundus photography has transformed from electronic flashes to smartphone-based cameras to a more recent portable eye examination kit (PEEK). PEEK is a smartphone-based application for a comprehensive eye examination. The advantage of these cameras is that a non-ophthalmologist can take pictures and, with some training, grade them as well. However, the optical coherence tomography segment is anticipated to register the highest CAGR of 8.1% in the market during the forecast period. The optical coherence tomography allows the evaluation of different levels of macular ischemia that are not diagnosed in primary imaging. The technique is used as a standard for imaging modalities for eyes.

End-User-Based Insights

Based on end-user, the global retinal imaging devices market is segmented into hospitals and clinics, specialty clinics, ambulatory care centers, and others. The hospitals & clinics segment held the largest share of the market in 2021 and specialized eye care centers is expected to register the highest CAGR of 6.6% in the market during the forecast period.

The regional trends and factors influencing the Retinal Imaging Devices Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Retinal Imaging Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Retinal Imaging Devices Market Report Scope

Retinal Imaging Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Retinal Imaging Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Regional Insights

Based on regions, the North America region accounted for the largest share in 2021 and is expected to follow a similar trend over the forecast period. The Asia Pacific region is expected to witness the highest growth rate over the forecast period. The application of Artificial intelligence (AI) and deep learning system (DLS) to improve screening coverage in Singapore is expected to assist the regional growth over the next seven years.

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the retinal imaging devices market players focus on the partnership strategy to expand their clientele, which, in turn, permits them to maintain their brand name across the world.

Based on device type, the retinal imaging devices market is categorized into fluorescein angiography, fundus camera and optical coherence tomography. Based on end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, specialized eye care centers and other end users. By geography, the retinal imaging devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).Some of the company profiles listed in our research scope are Carl Zeiss Meditec, Revenio Group Oyj, Nikon Corporation, Optomed, Topcon Corporation, Imagine Eyes, Epipole Ltd, Forus Health Pvt Ltd, Eyenuk Inc, and Phoenix Technology Group LLC amongst others.